How to Stop Taking Daily Aspirin Safely

Stopping daily aspirin is not as simple as skipping tomorrow’s pill. Whether you can safely quit depends almost entirely on why you started: people taking aspirin to prevent a first heart attack face a very different risk profile than those who already have heart disease, stents, or a history of stroke. A large Swedish cohort study found that people who stopped low-dose aspirin had roughly a 37% higher rate of cardiovascular events compared to those who continued, and the elevated risk appeared shortly after discontinuation and did not fade over time.¹ That finding does not mean everyone should stay on aspirin forever, but it does mean the way you stop matters as much as whether you stop.

Why the Reason You Started Aspirin Changes Everything

Doctors divide aspirin use into two broad categories. Primary prevention means you take aspirin to lower your chance of a heart attack or stroke that has never happened. Secondary prevention means you already have cardiovascular disease, have had a heart attack or stroke, or have a coronary stent. The distinction matters because the evidence behind each use is dramatically different, and so is the risk of quitting.

For primary prevention, the thinking has shifted. The U.S. Preventive Services Task Force now recommends against starting aspirin in adults 60 or older for primary prevention and says that for younger adults it should be a selective, individualized decision rather than a routine prescription.² Earlier meta-analyses of primary prevention trials showed aspirin cut heart attacks by about 30% but increased bleeding complications by roughly 69%, with gastrointestinal bleeding risk climbing as people aged. For many healthy adults, the bleeding risks now appear to outweigh the cardiovascular benefit. If you were started on aspirin years ago for primary prevention and your doctor agrees the guidelines have caught up with your situation, stopping is often the right call.

Secondary prevention is a different story. Aspirin remains a cornerstone of treatment for people with established heart disease. The evidence for continuing it in this group is strong and long-standing.³ If you have had a heart attack, a stroke, or stent placement, stopping aspirin without your cardiologist’s involvement is genuinely dangerous.

What Happens to Your Blood When You Quit Abruptly

Aspirin works by permanently disabling an enzyme in platelets, the cell fragments responsible for clotting. Each dose knocks out the clotting ability of every platelet circulating at that moment, and because platelets cannot repair themselves, the effect lasts for the entire lifespan of those platelets, roughly seven to ten days. Your body is constantly making new platelets, though, so the aspirin effect wears off gradually as fresh, fully functional platelets replace the disabled ones.

Studies tracking platelet recovery after aspirin cessation found that clotting function starts creeping back within about 72 hours and returns to normal baseline levels by roughly 96 hours, or four days.⁴ In surgical patients, who tend to have more variability, full recovery took closer to four to six days.⁵ This window is the danger zone. During those days, you go from having suppressed clotting to having it fully restored, and some researchers believe platelets may actually become somewhat hyperactive during the rebound, though the clinical significance of that rebound is still debated.

A UK case-control study found that people who recently stopped low-dose aspirin had about a 43% higher rate of heart attack or coronary death compared to those still taking it, translating to roughly four extra heart attacks per thousand patients over a year.⁶ That increase showed up soon after stopping. The Swedish cohort study, which followed over 600,000 aspirin users, found a similar pattern with about one additional cardiovascular event per year for every 74 people who quit.¹ These are averages across large populations that include both primary and secondary prevention users, so the risk for any individual depends on their baseline cardiovascular risk.

Steps to Discuss with Your Doctor Before Stopping

The single most important thing you can do is talk to your prescribing doctor before you change anything. That conversation should cover a few specific questions:

• Why was it prescribed? A quality-improvement project found that patients were more likely to stop aspirin inappropriately when they did not understand the reason they were taking it in the first place.⁷ Knowing whether your aspirin is for primary or secondary prevention changes the entire decision.
• Has your risk profile changed? If you started aspirin a decade ago when your blood pressure and cholesterol were poorly controlled, but you have since brought both under control with other medications and lifestyle changes, the calculus may be different now.
• Are you having side effects? Stomach upset, acid reflux, or a history of GI bleeding are legitimate reasons to reconsider, but they do not automatically mean you should stop. There are ways to manage the GI side effects while continuing aspirin.
• Are there upcoming procedures? Surgery is one of the most common reasons aspirin gets paused, and the timing of that pause matters enormously.

Some primary care practices have begun systematically reviewing charts to identify patients who are still on aspirin for primary prevention and flagging those cases for a shared-decision conversation with their doctor.⁸ If your doctor’s office has not raised the topic, you can raise it yourself.

Stopping Before Surgery

One of the most common scenarios for aspirin discontinuation is before an elective surgery. Surgeons want to minimize bleeding risk, but cardiologists worry about clot risk. Getting the timing right is tricky, and the evidence suggests it is frequently handled poorly. One hospital study found that nearly 47% of patients on long-term aspirin stopped it before surgery, and of those, almost 39% stopped either too early (more than ten days before) or too late (three days or fewer before).⁷ Stopping too early exposes you to unnecessary days without antiplatelet protection. Stopping too late may not give your platelets enough time to recover for safe surgery.

For many noncardiac surgeries, the evidence actually questions whether stopping is necessary at all. A large randomized trial of over 10,000 patients undergoing noncardiac surgery found that continuing aspirin did not reduce heart attacks or deaths (the rates were virtually identical between the aspirin and placebo groups), but it did slightly increase major bleeding.⁹ A smaller randomized trial in elective noncardiac surgery found no significant difference in complications between patients who maintained aspirin and those who switched to placebo.¹⁰ The upshot: for many surgeries, the decision is genuinely a toss-up, and the surgeon and anesthesiologist need to weigh the specific bleeding risk of the procedure against your cardiovascular risk.

If you and your surgical team decide that aspirin should be paused, the typical recommendation is to stop five to seven days before the procedure, which allows enough time for a new generation of platelets to enter circulation with full clotting ability. Your doctor will also tell you when to restart, usually within 24 to 48 hours after surgery or once any acute bleeding concern has passed.

Special Risks for People with Coronary Stents

If you have a coronary stent, the stakes of stopping aspirin are much higher. Stents are metal scaffolds that hold open a previously blocked artery, and the body naturally wants to form clots on foreign material. Antiplatelet drugs prevent stent thrombosis, which is a sudden clot forming inside the stent that can cause a massive heart attack. An early study of patients who stopped aspirin found that 20% of observed stent thrombosis cases involved bare-metal stents that had been implanted more than a year earlier, meaning even old stents remain vulnerable.¹¹

Interestingly, recent research has complicated the traditional “dual antiplatelet therapy” approach, where patients take both aspirin and a second antiplatelet drug for months after stent placement. A meta-analysis found that dropping aspirin early after stenting (while continuing a second antiplatelet agent like ticagrelor or clopidogrel) did not increase heart attacks, stent thrombosis, or strokes, and it cut major bleeding risk by about 42%.¹² A randomized trial in patients with acute coronary syndrome found that stopping aspirin at a median of 16 days after stenting while continuing ticagrelor alone was not just noninferior but actually superior to twelve months of dual therapy for the combined outcome of death, heart attack, stent thrombosis, stroke, and major bleeding.¹³

The key point here is that “stopping aspirin” is not the same as “stopping all antiplatelet protection.” Stent patients who drop aspirin typically continue a different blood thinner. Never stop any antiplatelet medication after stent placement without your cardiologist’s explicit instruction.

When GI Problems Are Pushing You to Quit

Stomach pain, heartburn, and gastrointestinal bleeding are among the most common reasons people want off aspirin. These are real and sometimes serious problems, but quitting aspirin cold turkey to fix your stomach may trade one risk for another. For many patients, the better approach is to keep aspirin while adding a proton pump inhibitor (PPI) to protect the stomach lining.

Research has shown that in patients who developed bleeding ulcers while on low-dose aspirin, continuing aspirin with a PPI resulted in somewhat higher rates of recurrent ulcer bleeding in the short term compared to stopping aspirin, but dramatically lower death rates. At eight weeks, the group that continued aspirin had an all-cause mortality rate of about 1% versus roughly 13% in the group that stopped. The deaths in the group that stopped aspirin were driven by cardiovascular and cerebrovascular events.¹⁴ That is a striking trade-off: the stomach bleed you are trying to avoid is scary, but the cardiovascular event you might trigger by stopping aspirin is often more lethal.

If PPIs themselves cause problems for you (long-term use has its own concerns including nutrient absorption issues), talk to your doctor about alternatives like H2-receptor blockers, though PPIs have been shown to be more effective at preventing aspirin-related ulcers. The point is that GI symptoms alone are rarely sufficient reason to abruptly discontinue aspirin. There are almost always intermediate solutions worth trying first.

Switching to a Different Antiplatelet Drug

Sometimes the goal is not to eliminate antiplatelet therapy but to swap aspirin for something that works differently or has a better side effect profile. Clopidogrel is the most common alternative. A meta-analysis comparing clopidogrel monotherapy to aspirin monotherapy after stent placement found that sticking with aspirin carried a higher risk of major cardiovascular events, minor bleeding, GI bleeding, and both ischemic and hemorrhagic stroke compared to clopidogrel.¹⁵ Another analysis of clopidogrel versus aspirin beyond one year after stent placement suggested clopidogrel offers a borderline ischemic benefit over aspirin in the longer term.¹⁶

A switch like this is not something you manage on your own. Your doctor will determine the overlap period, if any, and make sure the new drug is working before the old one is fully out of your system. Clopidogrel also has its own considerations, including genetic variability in how people metabolize it and its own set of drug interactions.

Drug Interactions That Can Undermine Aspirin Before You Even Stop It

Before focusing on how to stop aspirin, it is worth knowing that some common medications can quietly neutralize aspirin’s antiplatelet effect while you think you are still protected. Ibuprofen is the classic example. Because ibuprofen competes for the same binding site on the platelet enzyme that aspirin targets, taking ibuprofen regularly can block aspirin from doing its job. A pharmacokinetic modeling study found that when ibuprofen was taken three times daily alongside low-dose aspirin, the antiplatelet effect of aspirin was reduced starting on the second day, and that reduction persisted for more than three days after ibuprofen was stopped.¹⁷ Lab studies of human platelets confirmed that ibuprofen and several other common anti-inflammatory drugs significantly altered aspirin’s ability to inhibit platelet clumping.¹⁸

If you take over-the-counter pain relievers regularly while on aspirin, you could be walking around with far less antiplatelet protection than you or your doctor realize. This matters in the context of stopping aspirin, too: if you have been taking ibuprofen daily alongside your aspirin, your effective antiplatelet coverage may have already been reduced, which changes the risk calculus. When discussing stopping aspirin, mention any regular use of anti-inflammatory painkillers.

Lifestyle Changes That Matter After Stopping

If you and your doctor decide aspirin should stop, the cardiovascular risk that aspirin was managing does not disappear. It needs to be addressed by other means. A large study of people with established coronary heart disease found that sustaining three lifestyle changes, not smoking, regular physical activity at least four times a week, and following a Mediterranean-style diet, was associated with roughly a 62% lower risk of recurrent heart events and about a 59% lower risk of death compared to people who maintained none of these habits.¹⁹ Each additional ideal factor added benefit in a dose-response fashion.

None of this replaces aspirin in a person who genuinely needs it for secondary prevention. But for someone stopping aspirin because they were on it for primary prevention and the indication no longer applies, doubling down on the lifestyle factors that reduce cardiovascular risk is the most productive thing you can do. Blood pressure control, cholesterol management with statins if indicated, blood sugar control in diabetes, smoking cessation, regular exercise, and a heart-healthy diet form the real backbone of cardiovascular prevention. Aspirin was always an add-on, not a substitute for these foundations.

How Patients and Doctors Often Get This Wrong

One persistent problem is that patients frequently underestimate the risk of stopping aspirin compared to how their doctors assess it. The hospital-based study that tracked preoperative aspirin management found a clear gap: patients consistently rated the risks of aspirin cessation lower than their physicians did.⁷ That mismatch leads to people casually skipping their aspirin for days or weeks, sometimes because of a dental appointment, sometimes because they ran out of pills and did not refill the prescription right away, sometimes because they read a headline about aspirin risks and decided to stop on their own.

On the flip side, another common error is doctors leaving patients on aspirin for primary prevention long after the evidence shifted. The USPSTF updated its recommendation, but prescribing habits change slowly, and many patients are still taking daily aspirin that was started years ago under older guidelines. If you have been on aspirin for a long time and no one has revisited the decision, it is worth asking whether the original reason still holds up.

The overall picture is that both overtreating and undertreating are common. The fix is the same in both directions: an honest, specific conversation between you and your doctor about your current risk factors, your current medications, your side effects, and whether aspirin still belongs in your regimen. If the answer is to stop, doing it with a plan, on a specific timeline, with attention to what replaces the protection aspirin was providing, is the difference between a safe transition and an unnecessary cardiac event.